| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/30/2009 | WO2009030217A3 Propagation of primary cells and use thereof |
| 04/30/2009 | WO2009021163A3 Enhancing gene transfer |
| 04/30/2009 | WO2009020748A3 Antibody therapy for modulating function of intestinal receptors |
| 04/30/2009 | WO2009019312A3 Anti cd37 antibodies |
| 04/30/2009 | WO2008129563A3 Human mesenchymal stem cells and preparation thereof |
| 04/30/2009 | WO2008076747A3 Processes of producing fermentation products |
| 04/30/2009 | WO2008070616A3 METHODS AND COMPOSITIONS RELATED TO HIF-1α |
| 04/30/2009 | WO2008045952A3 Photoreceptor precursor cells |
| 04/30/2009 | WO2008001379A3 Activated myeloid cells for promoting tissue repair and detecting damaged tissue |
| 04/30/2009 | WO2007067280A3 Very small embryonic-like (vsel) stem cells and methods of isolating and using the same |
| 04/30/2009 | WO2007056352A3 Compositions and methods for controlling tissue factor signaling specificity |
| 04/30/2009 | WO2007053482A3 Novel herbicide resistance genes |
| 04/30/2009 | WO2007047979A3 Parthenogenic activation of human oocytes for the production of human embryonic stem cells |
| 04/30/2009 | WO2007047408A3 Promac signature application |
| 04/30/2009 | WO2007040912A3 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 04/30/2009 | WO2007035634A3 Device and method for hair growth from stem cells |
| 04/30/2009 | WO2007016366A3 Defined culture conditions of human embryonic stem cells |
| 04/30/2009 | WO2007016130A3 A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response |
| 04/30/2009 | WO2006138606A3 Cell signaling genes and related methods |
| 04/30/2009 | WO2006138478A3 Stimulation of toll-like receptors on t cells |
| 04/30/2009 | WO2006133353A3 Methods of facilitating neural cell survival using non-peptide and peptide bdnf neurotrophin mimetics |
| 04/30/2009 | WO2006130433A3 Treatment of ischemia using stem cells |
| 04/30/2009 | WO2006124356A3 Method for isolating dermal papilla cells and uses thereof |
| 04/30/2009 | WO2006122147A3 Alginate poly-l-lysine encapsulation as a technology for controlled differentiation of embryonic stem cells |
| 04/30/2009 | WO2006091535A3 Novel egg receptors for sperm proteins |
| 04/30/2009 | WO2006083964A3 Modified fusion molecules for treatment of allergic disease |
| 04/30/2009 | WO2006080952A3 Improved modalities for the treatment of degenerative diseases of the retina |
| 04/30/2009 | WO2005010169A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/30/2009 | US20090113573 Modification of Flavonoid Biosynthesis in Plants |
| 04/30/2009 | US20090113571 Root-specific phosphate transporter promoters |
| 04/30/2009 | US20090113569 Root-specific phosphate transporter promoters |
| 04/30/2009 | US20090113565 Methods for Detecting Fluorescent Proteins and Animals Having Fluorescent Proteins |
| 04/30/2009 | US20090113562 Novel T7 Phage Peptide Display System and Uses Thereof |
| 04/30/2009 | US20090113561 Gene trap cassettes for random and targeted conditional gene inactivation |
| 04/30/2009 | US20090111973 Monolconal antibody specific to single immunoglobulin and toll-interleukin-1 receptor domain (SIGIRR) for treatment of rheumatoid arthritis, osteoporosis and inflammatory bowel diseases |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | US20090111786 Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| 04/30/2009 | US20090111764 Mitochondrial selection |
| 04/30/2009 | US20090111756 Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus |
| 04/30/2009 | US20090111755 Methods for the use of inhibitors of antigen presentation by mhc class ii molecules |
| 04/30/2009 | US20090111753 Nogo-A Polypeptide Fragments, Variant Nogo Receptor-1 Polypeptides, and Uses Thereof |
| 04/30/2009 | US20090111745 Plad Domain Peptides With Increased Serum Half Life Due To Conjugation To Domain Antibodies |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111741 Method for treating and/or preventing drug seeking behavior |
| 04/30/2009 | US20090111186 regulatory nucleotide sequence for obtaining a transformed plants and seeds; increase in yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance and salt tolerance in plants |
| 04/30/2009 | US20090111185 Female genome selection |
| 04/30/2009 | US20090111184 Chromosome selection |
| 04/30/2009 | US20090111182 Method for Propagation of Plant |
| 04/30/2009 | US20090111181 Apparatus for preparing a biocompatible matrix |
| 04/30/2009 | US20090111180 Bioreactor system for three-dimensional tissue stimulator |
| 04/30/2009 | US20090111179 Cell Culture Shaking Device and Shaking Culture Method as Cell Culture Method |
| 04/30/2009 | US20090111178 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein |
| 04/30/2009 | US20090111177 Maintenance of Embryonic Stem Cells by the GSK-3 Inhibitor 6-Bromoindirubin-3'-Oxime |
| 04/30/2009 | US20090111176 Trehalose transporter gene and method of introducing trehalose into cells |
| 04/30/2009 | US20090111146 Antibody Drug |
| 04/30/2009 | US20090111144 Transactivation system for mammalian cells |
| 04/30/2009 | US20090111143 Methods and Compositions for Mammalian Cell Lines for Transfection and Protein Expression in Serum-Free Medium |
| 04/30/2009 | US20090111142 Method for manufacturing a recombinant polyclonal protein |
| 04/30/2009 | US20090111126 Mammalian cell-based immunoglobulin display libraries |
| 04/30/2009 | US20090111123 Compositions for detecting antibodies to babesia microti and methods of uses thereof |
| 04/30/2009 | US20090111109 Genes relating to gastric cancer metastasis |
| 04/30/2009 | US20090111107 Tumor suppressor gene p33ing2 |
| 04/30/2009 | US20090111106 Vector System |
| 04/30/2009 | US20090111098 Reporter gene assay |
| 04/30/2009 | US20090111087 Separation method of Nucleated Cells Derived from Bone Marrow for Bone Formation |
| 04/30/2009 | US20090110701 T-cell modulation |
| 04/30/2009 | US20090110694 Anti-Inflammatory Proteins and Improved Vaccines |
| 04/30/2009 | US20090110690 Hiv Gp120 Crystal Structure and Its Use to Identify Immunogens |
| 04/30/2009 | US20090110687 Compositions and methods related to tim 3, a th1-specific cell surface molecule |
| 04/30/2009 | US20090110686 Antibodies against CCR5 and uses thereof |
| 04/30/2009 | US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation |
| 04/30/2009 | US20090110678 Receptor antagonists for treatment of metastatic bone cancer |
| 04/30/2009 | US20090110673 Methods of reducing cell death following hypoxia / reoxygenation |
| 04/30/2009 | US20090110669 Methods for improving cell line activity in immunoisolation devices |
| 04/30/2009 | US20090110668 Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor |
| 04/30/2009 | US20090110637 LMP and Regulation of Tissue Growth |
| 04/30/2009 | US20090110632 Biological materials and uses thereof |
| 04/30/2009 | DE102007063660A1 Injektionseinrichtung zur Injektion in biologisches Gewebe und Injektionsdepot Injection means for injecting into biological tissue and injection depot |
| 04/30/2009 | CA2741403A1 Induction of pluripotent stem cells into mesodermal lineages |
| 04/30/2009 | CA2703787A1 Antibody directed against pro-gastrin releasing peptide, and use thereof |
| 04/30/2009 | CA2703736A1 Genetic incorporation of 3-aminotyrosine into reductases |
| 04/30/2009 | CA2703672A1 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction |
| 04/30/2009 | CA2703493A1 A cell for use in production of heteroproteins and production method using the same |
| 04/30/2009 | CA2702924A1 Novel atp:citrate lyase genes |
| 04/30/2009 | CA2660123A1 Nuclear reprogramming method |
| 04/30/2009 | CA2607915A1 New cell models |
| 04/29/2009 | EP2053128A1 Novel method for utilization of microbial mutant |
| 04/29/2009 | EP2053127A2 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 04/29/2009 | EP2053123A1 Method of proliferating lak cell |
| 04/29/2009 | EP2053063A1 Recognition molecules for treatment and detection of tumours |
| 04/29/2009 | EP2052077A1 Genetically modified plants which synthesize a starch having increased swelling power |
| 04/29/2009 | EP2052076A1 Method of identifying cd4+cd25+ t cells activated to an antigen which express cd8 |
| 04/29/2009 | EP2052075A1 Manufacturing method of activated lymphocytes for immunotherapy |
| 04/29/2009 | EP2051997A1 Anti-c5ar antibodies with improved properties |
| 04/29/2009 | EP2051988A2 Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 04/29/2009 | EP2051720A2 Oocyte maturation method |
| 04/29/2009 | EP2051718A2 Mesenchymal stem cells and uses therefor |
| 04/29/2009 | EP1896568A4 Components of cell culture media produced from plant cells |
| 04/29/2009 | EP1781774A4 Amorphous cell delivery vehicle treated with physical/physicochemical stimuli |